SELECTED'ABSTRACTS'FOR'POSTER'PRESENTATIONS'
IN'ALPHABETIC'ORDER'ACCORDING'TO'THE'NAME'OF'THE'FIRST'AUTHOR'
'
BIOLOGY'POSTERS'
'
Poster'1:'' GENETIC' INVESTIGATION' OF' APOPTOTIC' GENES' IN' FAMILIAL' CASES' OF'
LYMPHOMA'
Walid&Sabri&Hamadou&
'
Poster'2:'' LENALIDOMIDE' IN' COMBINATION' WITH' ARSENIC' TRIOXIDE:' AN' EFFECTIVE'
THERAPY'FOR'PRIMARY'EFFUSION'LYMPHOMA'
! Sara& Moodad,& Rana& El& Hajj,& Rita& Hleihel,& Layal& Hajjar,& Nadim& Tawil,& Martin& Karam,&
Maguy&Hamieh,&Raghida&Abou&Merhi,&Marwan&El&Sabban,&Hiba&El&Hajj&
&
Poster'3:'' RNA'SEQUENCING'ANALYSIS'IN'PRIMARY'MEDIASTINAL'B'CELL'LYMPHOMA:'
IDENTIFICATION' OF' DIFFERENT' GENE' EXPRESSION' RELATED' TO'
CHEMORESISTANCE'
Guido& Eugenio& Parvis,& Danny& Incarnato,& Davide& Torti,& Ubaldo& Familiari,& Francesco&
Vassallo,& Giovanna& Carrà,& Salvatore& Oliviero,& Marco& Volante,& Angelo& Guerrasio,&
Giuseppe&Saglio,&Alessandro&Morotti&
'
Poster'4:'' BENEFIT'OF'THE'BLOOD'SMEAR'IN'THE'DIAGNOSIS'OF'SEZARY'SYNDROME':'
A'CASE'REPORT'
! Wafa&Quiddi,&Hiba&Boumaazi,&Sanae&Sayagh&
&
Poster'5:'' TYPICAL' IMAGES' OF' SÉZARY' CELLS' IN' PERIPHERAL' BLOOD' SMEAR' FROM' A'
PATIENT'WITH'STAGE'IIIB'OF'SÉZARY'SYNDROME'
Sanae& Sayagh,& Adil& Jahdaoui,& Fatima& Zahra& Rahali,& Said& Amal,& Mustapha& Ait& Ameur,&
Mohamed&Chakour&
'
Poster'6:'' МICELLAR' CURCUMIN' SUBSTANTIALLY' INCREASES' THE' ANTINEOPLASTIC'
AND' ANTIMICROBIAL' EFFICACY' OF' ЕRUFOSINE' AGAINST' TWIST1' POSITIVE'
CUTANEOUS' TICELL' LYMPHOMA' CELLS' AND' GRAMIPOSITIVE' PATHOGENIC'
BACTERIA'
! Maya&M&Zaharieva,&Antonios&Trochopoulos,&Yana&Illieva,&Alexander&Kroumov,&Lyudmila&
Dimitrova,&Stanislav&Philipov,&Ivanka&PenchevaVEl&Tibi,&Krassimira&Yoncheva,&Martin&R.&
Berger,&Hristo&Najdenski,&Spiro&Konstantinov&
&
!
&
&
' '
SCIENTIFIC PROGRAMME
SESSION I
HODGKIN’S DISEASE
DEBATE I
IS THERE STILL A ROLE
FOR COMBINED MODALITY
THERAPY FOR EARLY
STAGE CHL?
SESSION II
T-CELL LYMPHOMA
ROUNDTABLE I
FUTURE DIRECTIONS IN
T-CELL LYMPHOMA
SESSION III
FOLLICULAR LYMPHOMA
DEBATE II
CAN WE AVOID
CHEMOTHERAPY IN
THE MANAGEMENT OF
FOLLICULAR LYMPHOMA?
SESSION IV
RARE LYMPHOMAS –
MARGINAL ZONE
LYMPHOMA AND
WALDENSTRÖM M
ACROGLOBULINEMIA
ROUNDTABLE II – WHERE
TO GO IN RARE B-CELL
LYMPHOMAS
SESSION V
MANTLE CELL LYMPHOMA
SESSION VI
DIFFUSE LARGE B-CELL
LYMPHOMA
DEBATE III
DO WE STILL NEED ASCT
IN MCL?
SESSION VII
NOVEL THER APEUTIC
CONCEPTS IN B-CELL
LYMPHOMAS
SELECTED ABSTRACTS
FOR AN ORAL
PRESENTATION
SELECTED ABSTRACTS
FOR A POSTER
PRESENTATION
DISCLOSURES